# Biological Motif Asset Pack v0.3 Review

Date: 2026-06-02

Purpose:

- move beyond the v0.2 icon-like motif pack;
- create a smaller P0 biological visual system with source-like schematic
  texture plates;
- add editable overlays and trust metadata so motifs do not overclaim evidence.

## Output

Asset root:

- `assets/biovis_motif_pack_v0_3/`

Generated assets:

- `assets/biovis_motif_pack_v0_3/png/`
- `assets/biovis_motif_pack_v0_3/overlay_svg/`
- `assets/biovis_motif_pack_v0_3/manifest.json`
- `assets/biovis_motif_pack_v0_3/manifest.csv`
- `assets/biovis_motif_pack_v0_3/biovis_motif_pack_v0_3_contact_sheet.png`
- `assets/biovis_motif_pack_v0_3/biovis_motif_pack_v0_3_usage_sheet.png`
- `assets/biovis_motif_pack_v0_3/biovis_motif_pack_v0_3_grayscale_qa.png`
- `assets/biovis_motif_pack_v0_3/qa/biovis_motif_pack_v0_3_qa.json`

Bridge context test:

- `output/premium_feature_layer_bridge_v0_3_test/feature_layer_bridge_v0_3_motif_test.png`
- `output/premium_feature_layer_bridge_v0_3_test/feature_layer_bridge_v0_3_motif_test.pdf`
- `output/premium_feature_layer_bridge_v0_3_test/feature_layer_bridge_v0_3_motif_test_manifest.json`
- `output/premium_feature_layer_bridge_v0_3_test/feature_layer_bridge_v0_3_motif_test_qa.json`

Generator:

- `scripts/build_biovis_motif_asset_pack_v3.py`

Research basis:

- `docs/BIOVIS_MOTIF_V0_3_DEEP_RESEARCH_2026_06_02.md`

## Why v0.3 Was Needed

v0.2 improved polish, but remained too close to an icon pack.

Main v0.2 limitations:

- repeated oval glow grammar;
- organ/tissue/cellular/molecular motifs were too similar in visual language;
- no source tags, scale cues, species grammar, or modality grammar;
- weak grayscale discipline;
- not enough biological materiality for premium slide openers.

## v0.3 Design Change

v0.3 reframes the pack as a biological visual system.

Each P0 asset now has:

- a 1600 x 900 PNG texture plate;
- an editable SVG overlay;
- biological level;
- modality;
- species or model-system scope;
- evidence status;
- allowed uses;
- prohibited uses.

The intended slide role is:

> Z2 proof-like texture plus Z3/Z4 editable scientific interpretation.

The asset must not replace measured source evidence.

## P0 Assets

Generated P0 set:

- `cell_micrograph_texture_field`
- `tissue_section_texture_field`
- `organoid_rosette_texture_field`
- `spatial_spot_section_field`
- `single_cell_embedding_field`
- `omics_matrix_texture_field`
- `pathway_network_summary_field`
- `species_model_strip`

## Manual Visual QA

Contact sheet:

- pass: image orientation corrected after initial flip issue;
- pass: assets now read more like biological texture plates than simple icons;
- pass: metadata labels make evidence status explicit;
- conditional pass: organoid, pathway, and species strip remain more schematic
  than source-like.

Usage sheet:

- pass: 3840 x 2160 usage sheet inspected;
- pass: Z3 text collision fixed;
- pass: v0.3 integrates better than v0.2 as a layered biological context system;
- conditional pass: bright schematic plates still need careful placement on
  pale slides.

Grayscale QA:

- pass: shape, density, and label structure survive without color;
- pass: single-cell embedding, spatial spots, pathway clusters, and species
  strip remain interpretable;
- conditional pass: true colorblind simulation should still be added later.

Bridge replacement test:

- pass: v0.3 omics matrix, single-cell embedding, pathway network, and species
  strip read as stronger biological/data texture than v0.2 motifs;
- pass: labels and left-to-right flow remain readable at 3840 x 2160;
- conditional pass: this is a context stress test, not a final slide;
- limitation: final slide should remove the meta-test title, crop plates more
  assertively, raise contrast, and replace schematic panels with source-derived
  proof when empirical figures are locked.

## Asset-Level Notes

Strongest assets:

- `cell_micrograph_texture_field`: best source-like biological materiality;
- `omics_matrix_texture_field`: strong fit for feature-layer and preprocessing
  slides;
- `single_cell_embedding_field`: useful modality texture for v9/sc-spaceflight
  context;
- `spatial_spot_section_field`: clearer than the v0.2 spatial motif and more
  useful for future modality explanation.

Adequate but still schematic:

- `tissue_section_texture_field`: improved from jagged contour to smoother
  histology-like tissue field, but still not source-derived;
- `organoid_rosette_texture_field`: better density and rosette grammar, but
  still symbolic;
- `pathway_network_summary_field`: useful as interpretation layer, not proof;
- `species_model_strip`: valuable because it explicitly labels species rather
  than relying on ambiguous silhouettes.

## Claim Boundary

Allowed:

- use as generated schematic biological texture;
- use as slide context for feature layers, modalities, species scope, and
  method bridges;
- use with labels that clarify "not source evidence";
- use as a visual placeholder before source-derived plates are selected.

Avoid:

- presenting these as microscopy, histology, spatial, or omics results;
- implying that all species listed are analyzed in the current result;
- using organoid assets in core claims unless the slide clearly marks
  extension/future scope;
- using pathway network geometry as causal pathway evidence.

## Remaining Gap

v0.3 is a meaningful step, but not the final premium biological visual language.

Remaining needs:

- source-derived or source-inspired texture exploration;
- colorblind simulation beyond grayscale;
- direct replacement test inside the actual feature-layer bridge with final
  non-meta title and stronger plate contrast;
- one microscopy-like high-impact section opener;
- species/modality badge system that can be used in native PPT text layers;
- image-license manifest if any external source textures are introduced.

## Verdict

Conditional pass as v0.3 P0 prototype.

This is materially stronger than v0.2 because it introduces biological levels,
modalities, species scope, evidence status, grayscale QA, and editable overlays.
It is suitable for controlled slide tests, but not yet sufficient to replace
source-derived proof figures in high-profile manuscript-style panels.
